Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy

Research output: Contribution to journalArticle

Abstract

Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.

Original languageEnglish
Article number600
JournalBMC Infectious Diseases
Volume13
Issue number1
DOIs
Publication statusPublished - Dec 21 2013

Fingerprint

Kaposi's Sarcoma
Brain
Central Nervous System
Virus Diseases
Therapeutics
HIV-1
Immunity
Radiotherapy
HIV
Drug Therapy
Human Herpesvirus 8
Skin
Highly Active Antiretroviral Therapy
Viral Load
Squamous Cell Carcinoma
Autopsy
Neoplasms
Histology
Acquired Immunodeficiency Syndrome
Differential Diagnosis

Keywords

  • Central nervous system
  • Combination antiretroviral therapy
  • HHV-8
  • HIV
  • Kaposi's sarcoma

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

@article{6bcea821f3aa409b8d6179afb0407e8e,
title = "Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy",
abstract = "Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.",
keywords = "Central nervous system, Combination antiretroviral therapy, HHV-8, HIV, Kaposi's sarcoma",
author = "Francesco Baldini and Andrea Baiocchini and Vincenzo Schinin{\`a} and Chiara Agrati and Giancola, {Maria L.} and Lucia Alba and Susanna Grisetti and {Del Nonno}, Franca and Capobianchi, {Maria R.} and Andrea Antinori",
year = "2013",
month = "12",
day = "21",
doi = "10.1186/1471-2334-13-600",
language = "English",
volume = "13",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy

AU - Baldini, Francesco

AU - Baiocchini, Andrea

AU - Schininà, Vincenzo

AU - Agrati, Chiara

AU - Giancola, Maria L.

AU - Alba, Lucia

AU - Grisetti, Susanna

AU - Del Nonno, Franca

AU - Capobianchi, Maria R.

AU - Antinori, Andrea

PY - 2013/12/21

Y1 - 2013/12/21

N2 - Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.

AB - Background: Central nervous system is a very rare site of Kaposi's sarcoma in acquired immunodeficiency syndrome. Kaposi's sarcoma, a neoplasm of endothelial origin, occurs mainly in the skin, but can involve many tissues, especially in patients with a poor immunity. Combination antiretroviral therapy, highly active against human immunodeficiency virus type-1, has caused a dramatic reduction of cutaneous and visceral involvements. No report of central nervous system localization of Kaposi's sarcoma is described since the introduction of combination antiretroviral therapy in the late 90's. Case presentation: A 42 year-old Caucasian man affected by human immunodeficiency virus type-1 infection treated with combination antiretroviral therapy and showing relatively preserved immunity with low viral load presented gingival squamous cell carcinoma and visceral (lungs and lymph nodes) Kaposi's sarcoma. Chemotherapy and radiotherapy were performed with improvement of both neoplasms. Afterwards, a magnetic resonance imaging showed focal lesions of the brain. Despite new chemotherapy and radiotherapy the patient died. Histology after autopsy revealed brain lesions due to Kaposi's sarcoma with the detection of Human Herpesvirus 8 on tissue samples. Conclusions: This is the first report in the combination antiretroviral therapy era of a very rare complication of Kaposi's sarcoma, such as that of brain localization, in a patient with a relatively good control of human immunodeficiency virus infection. Therefore, Kaposi's sarcoma should be considered in differential diagnosis with other intracranial mass lesions that can occur in human immunodeficiency virus infected-patients focusing the issue of appropriate treatment for central nervous system involvement.

KW - Central nervous system

KW - Combination antiretroviral therapy

KW - HHV-8

KW - HIV

KW - Kaposi's sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84890478159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890478159&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-13-600

DO - 10.1186/1471-2334-13-600

M3 - Article

C2 - 24359263

AN - SCOPUS:84890478159

VL - 13

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 600

ER -